Oculis Strengthens its Global Clinical and Business Development Capabilities Through Strategic Appointments to Senior Management Team

LAUSANNE, Switzerland, November 20, 2018 -- (Healthcare Sales & Marketing Network) -- Oculis, a clinical-stage biopharmaceutical company developing next-generation topical ophthalmic treatments for acute and chronic back- and front-of-the-eye diseases, an... Biopharmaceuticals, Ophthalmology, Personnel Oculis, OC-118, solubilizing nanoparticle
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news